Cargando…

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand

BACKGROUND: Multidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major public health problem, and early detection is important for preventing its spread. This study aimed to demonstrate the distribution of genetic site mutation associated with drug resistance in M/XDR-TB in the northern...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaksuwan, Risara, Tharavichikul, Prasit, Patumanond, Jayanton, Chuchottaworn, Charoen, Chanwong, Sakarin, Smithtikarn, Saijai, Settakorn, Jongkolnee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495008/
https://www.ncbi.nlm.nih.gov/pubmed/28706448
http://dx.doi.org/10.2147/IDR.S130203
_version_ 1783247752245805056
author Jaksuwan, Risara
Tharavichikul, Prasit
Patumanond, Jayanton
Chuchottaworn, Charoen
Chanwong, Sakarin
Smithtikarn, Saijai
Settakorn, Jongkolnee
author_facet Jaksuwan, Risara
Tharavichikul, Prasit
Patumanond, Jayanton
Chuchottaworn, Charoen
Chanwong, Sakarin
Smithtikarn, Saijai
Settakorn, Jongkolnee
author_sort Jaksuwan, Risara
collection PubMed
description BACKGROUND: Multidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major public health problem, and early detection is important for preventing its spread. This study aimed to demonstrate the distribution of genetic site mutation associated with drug resistance in M/XDR-TB in the northern Thai population. METHODS: Thirty-four clinical MTB isolates from M/XDR-TB patients in the upper northern region of Thailand, who had been identified for drug susceptibility using the indirect agar proportion method from 2005 to 2012, were examined for genetic site mutations of katG, inhA, and ahpC for isoniazid (INH) drug resistance and rpoB for rifampicin (RIF) drug resistance. The variables included the baseline characteristics of the resistant gene, genetic site mutations, and drug susceptibility test results. RESULTS: All 34 isolates resisted both INH and RIF. Thirty-two isolates (94.1%) showed a mutation of at least 1 codon for katG, inhA, and ahpC genes. Twenty-eight isolates (82.4%) had a mutation of at least 1 codon of rpoB gene. The katG, inhA, ahpC, and rpoB mutations were detected in 20 (58.7%), 27 (79.4%), 13 (38.2%), and 28 (82.3%) of 34 isolates. The 3 most common mutation codons were katG 315 (11/34, 35.3%), inhA 14 (11/34, 32.4%), and inhA 114 (11/34, 32.4%). For this population, the best genetic mutation test panels for INH resistance included 8 codons (katG 310, katG 340, katG 343, inhA 14, inhA 84, inhA 86, inhA 114, and ahpC 75), and for RIF resistance included 6 codons (rpoB 445, rpoB 450, rpoB 464, rpoB 490, rpoB 507, and rpoB 508) with a sensitivity of 94.1% and 82.4%, respectively. CONCLUSION: The genetic mutation sites for drug resistance in M/XDR-TB are quite variable. The distribution of these mutations in a certain population must be studied before developing the specific mutation test panels for each area. The results of this study can be applied for further molecular M/XDR-TB diagnosis in the upper northern region of Thailand.
format Online
Article
Text
id pubmed-5495008
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54950082017-07-13 Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand Jaksuwan, Risara Tharavichikul, Prasit Patumanond, Jayanton Chuchottaworn, Charoen Chanwong, Sakarin Smithtikarn, Saijai Settakorn, Jongkolnee Infect Drug Resist Original Research BACKGROUND: Multidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major public health problem, and early detection is important for preventing its spread. This study aimed to demonstrate the distribution of genetic site mutation associated with drug resistance in M/XDR-TB in the northern Thai population. METHODS: Thirty-four clinical MTB isolates from M/XDR-TB patients in the upper northern region of Thailand, who had been identified for drug susceptibility using the indirect agar proportion method from 2005 to 2012, were examined for genetic site mutations of katG, inhA, and ahpC for isoniazid (INH) drug resistance and rpoB for rifampicin (RIF) drug resistance. The variables included the baseline characteristics of the resistant gene, genetic site mutations, and drug susceptibility test results. RESULTS: All 34 isolates resisted both INH and RIF. Thirty-two isolates (94.1%) showed a mutation of at least 1 codon for katG, inhA, and ahpC genes. Twenty-eight isolates (82.4%) had a mutation of at least 1 codon of rpoB gene. The katG, inhA, ahpC, and rpoB mutations were detected in 20 (58.7%), 27 (79.4%), 13 (38.2%), and 28 (82.3%) of 34 isolates. The 3 most common mutation codons were katG 315 (11/34, 35.3%), inhA 14 (11/34, 32.4%), and inhA 114 (11/34, 32.4%). For this population, the best genetic mutation test panels for INH resistance included 8 codons (katG 310, katG 340, katG 343, inhA 14, inhA 84, inhA 86, inhA 114, and ahpC 75), and for RIF resistance included 6 codons (rpoB 445, rpoB 450, rpoB 464, rpoB 490, rpoB 507, and rpoB 508) with a sensitivity of 94.1% and 82.4%, respectively. CONCLUSION: The genetic mutation sites for drug resistance in M/XDR-TB are quite variable. The distribution of these mutations in a certain population must be studied before developing the specific mutation test panels for each area. The results of this study can be applied for further molecular M/XDR-TB diagnosis in the upper northern region of Thailand. Dove Medical Press 2017-06-10 /pmc/articles/PMC5495008/ /pubmed/28706448 http://dx.doi.org/10.2147/IDR.S130203 Text en © 2017 Jaksuwan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Jaksuwan, Risara
Tharavichikul, Prasit
Patumanond, Jayanton
Chuchottaworn, Charoen
Chanwong, Sakarin
Smithtikarn, Saijai
Settakorn, Jongkolnee
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
title Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
title_full Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
title_fullStr Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
title_full_unstemmed Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
title_short Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
title_sort genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern thailand
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495008/
https://www.ncbi.nlm.nih.gov/pubmed/28706448
http://dx.doi.org/10.2147/IDR.S130203
work_keys_str_mv AT jaksuwanrisara genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand
AT tharavichikulprasit genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand
AT patumanondjayanton genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand
AT chuchottaworncharoen genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand
AT chanwongsakarin genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand
AT smithtikarnsaijai genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand
AT settakornjongkolnee genotypicdistributionofmultidrugresistantandextensivelydrugresistanttuberculosisinnorthernthailand